GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zenotech Laboratories Ltd (BOM:532039) » Definitions » Price-to-Owner-Earnings

Zenotech Laboratories (BOM:532039) Price-to-Owner-Earnings : 118.63 (As of Jun. 16, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Zenotech Laboratories Price-to-Owner-Earnings?

As of today (2024-06-16), Zenotech Laboratories's share price is ₹61.69. Zenotech Laboratories's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹0.52. It's Price-to-Owner-Earnings for today is 118.63.


The historical rank and industry rank for Zenotech Laboratories's Price-to-Owner-Earnings or its related term are showing as below:

BOM:532039' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.94   Med: 19.54   Max: 137.86
Current: 119.09

During the past 13 years, the highest Price-to-Owner-Earnings of Zenotech Laboratories was 137.86. The lowest was 8.94. And the median was 19.54.


BOM:532039's Price-to-Owner-Earnings is ranked worse than
91.76% of 425 companies
in the Drug Manufacturers industry
Industry Median: 24.87 vs BOM:532039: 119.09

As of today (2024-06-16), Zenotech Laboratories's share price is ₹61.69. Zenotech Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.36. Therefore, Zenotech Laboratories's PE Ratio for today is 45.36.

As of today (2024-06-16), Zenotech Laboratories's share price is ₹61.69. Zenotech Laboratories's EPS without NRI for the trailing twelve months (TTM) ended in was ₹1.36. Therefore, Zenotech Laboratories's PE Ratio without NRI for today is 45.36.

During the past 13 years, Zenotech Laboratories's highest PE Ratio without NRI was 242.81. The lowest was 12.06. And the median was 35.15.


Zenotech Laboratories Price-to-Owner-Earnings Historical Data

The historical data trend for Zenotech Laboratories's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenotech Laboratories Price-to-Owner-Earnings Chart

Zenotech Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.11 - 14.26 27.55 114.11

Zenotech Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.55 - - - 114.11

Competitive Comparison of Zenotech Laboratories's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Zenotech Laboratories's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenotech Laboratories's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zenotech Laboratories's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Zenotech Laboratories's Price-to-Owner-Earnings falls into.



Zenotech Laboratories Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Zenotech Laboratories's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=61.69/0.52
=118.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zenotech Laboratories  (BOM:532039) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Zenotech Laboratories Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Zenotech Laboratories's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenotech Laboratories (BOM:532039) Business Description

Traded in Other Exchanges
N/A
Address
Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.

Zenotech Laboratories (BOM:532039) Headlines

No Headlines